September 16, 2025 • 4 mins
Welcome to Ozempic Weightloss Unlocked, your source for the latest news, research, and insights on Ozempic and its impact on weight loss, health, and lifestyle.
If you are following updates on Ozempic, recent international studies are shedding a spotlight on why so many are both drawn to and dropping away from this buzzy medication. According to reports from HealthDay and Drugs.com, about half of the adults who start Ozempic for weight loss end up quitting within just one year. For context, a study out of Denmark tracked more than seventy-seven thousand new Ozempic users and found that fifty-two percent gave it up before the year's end. These findings were presented at this year's European Association for the Study of Diabetes meeting in Vienna.
So, why are so many discontinuing Ozempic? One major reason is cost. In Denmark, the lowest possible annual dose is over two thousand euros. In the United States, prices can jump to more than one thousand four hundred dollars monthly if uninsured. People in lower-income areas were nearly fifteen percent more likely to quit early. For many, the price tag is simply not sustainable long-term.
Side effects are another factor. Drugs.com highlights that those with gastrointestinal conditions, chronic illnesses, or who are taking psychiatric medication are more likely to stop using Ozempic. The Danish study found that people with existing GI issues were nine percent more likely to quit, and those with heart disease or other chronic conditions were ten percent more likely to stop. Furthermore, common side effects like nausea, vomiting, and diarrhea disproportionately drive users to discontinue.
Age and gender play a role too. Younger adults were forty-eight percent more likely to stop Ozempic within the first year compared to older users. Men had a twelve percent greater likelihood than women to quit. The study authors note that women tend to see slightly better weight loss results, which might help motivate their continued use.
One important medical application is for people living with diabetes. Originally, Ozempic and similar drugs were developed to help manage blood sugar. However, they've gained popularity strictly for weight loss, and over ninety percent of new prescriptions in some studies are written for those without diabetes.
Another recent clinical trial, reported by TheJournal.ie, looked at bumping up the standard dose to see if results improve. By tripling the weekly dosage to seven-point-two milligrams, nearly half of trial participants lost at least twenty percent of their body weight. But remember, higher doses may also lead to more side effects and costs.
For younger women who are considering Ozempic, caution is warranted. According to researchers at Flinders University, there are hidden reproductive risks for women in their childbearing years. The Medical Journal of Australia reports that most women prescribed Ozempic are not using effective contraception, even though these medications can pose risks during pregnancy and fetal development. Only twenty-one percent of women on Ozempic were using contraception in one large study of more than one-point-six million general practice records. Notably, women with polycystic ovary syndrome were twice as likely to conceive after starting Ozempic, possibly because weight loss can improve fertility. Lead researcher Associate Professor Luke Grzeskowiak states the need for proper counseling on reproductive risks for women starting these drugs.
A final point from ScienceDaily is that stopping Ozempic often leads to regaining weight. Because the drug works by curbing appetite and promoting the feeling of fullness, these benefits disappear once you stop. For most, it is not a quick fix but a long-term commitment.
As awareness rises, so does the number of questions around cost, access, side effect management, and the balance of risks and benefits. Whether you are considering Ozempic, currently taking it, or simply curious about its role in the future of weight management, keeping up with peer-reviewed research and evolving guidelines from health agencies is crucial.
Thank you for tuning in to Ozempic Weightloss Unlocked. If you found this episode helpful, please remember to subscribe so you do not miss our next update. This has been a quiet please production, for more check out quiet please dot ai.
Some great Deals https://amzn.to/49SJ3Qs
For more check out http://www.quietplease.ai
This content was created in partnership and with the help of Artificial Intelligence AI
If you are following updates on Ozempic, recent international studies are shedding a spotlight on why so many are both drawn to and dropping away from this buzzy medication. According to reports from HealthDay and Drugs.com, about half of the adults who start Ozempic for weight loss end up quitting within just one year. For context, a study out of Denmark tracked more than seventy-seven thousand new Ozempic users and found that fifty-two percent gave it up before the year's end. These findings were presented at this year's European Association for the Study of Diabetes meeting in Vienna.
So, why are so many discontinuing Ozempic? One major reason is cost. In Denmark, the lowest possible annual dose is over two thousand euros. In the United States, prices can jump to more than one thousand four hundred dollars monthly if uninsured. People in lower-income areas were nearly fifteen percent more likely to quit early. For many, the price tag is simply not sustainable long-term.
Side effects are another factor. Drugs.com highlights that those with gastrointestinal conditions, chronic illnesses, or who are taking psychiatric medication are more likely to stop using Ozempic. The Danish study found that people with existing GI issues were nine percent more likely to quit, and those with heart disease or other chronic conditions were ten percent more likely to stop. Furthermore, common side effects like nausea, vomiting, and diarrhea disproportionately drive users to discontinue.
Age and gender play a role too. Younger adults were forty-eight percent more likely to stop Ozempic within the first year compared to older users. Men had a twelve percent greater likelihood than women to quit. The study authors note that women tend to see slightly better weight loss results, which might help motivate their continued use.
One important medical application is for people living with diabetes. Originally, Ozempic and similar drugs were developed to help manage blood sugar. However, they've gained popularity strictly for weight loss, and over ninety percent of new prescriptions in some studies are written for those without diabetes.
Another recent clinical trial, reported by TheJournal.ie, looked at bumping up the standard dose to see if results improve. By tripling the weekly dosage to seven-point-two milligrams, nearly half of trial participants lost at least twenty percent of their body weight. But remember, higher doses may also lead to more side effects and costs.
For younger women who are considering Ozempic, caution is warranted. According to researchers at Flinders University, there are hidden reproductive risks for women in their childbearing years. The Medical Journal of Australia reports that most women prescribed Ozempic are not using effective contraception, even though these medications can pose risks during pregnancy and fetal development. Only twenty-one percent of women on Ozempic were using contraception in one large study of more than one-point-six million general practice records. Notably, women with polycystic ovary syndrome were twice as likely to conceive after starting Ozempic, possibly because weight loss can improve fertility. Lead researcher Associate Professor Luke Grzeskowiak states the need for proper counseling on reproductive risks for women starting these drugs.
A final point from ScienceDaily is that stopping Ozempic often leads to regaining weight. Because the drug works by curbing appetite and promoting the feeling of fullness, these benefits disappear once you stop. For most, it is not a quick fix but a long-term commitment.
As awareness rises, so does the number of questions around cost, access, side effect management, and the balance of risks and benefits. Whether you are considering Ozempic, currently taking it, or simply curious about its role in the future of weight management, keeping up with peer-reviewed research and evolving guidelines from health agencies is crucial.
Thank you for tuning in to Ozempic Weightloss Unlocked. If you found this episode helpful, please remember to subscribe so you do not miss our next update. This has been a quiet please production, for more check out quiet please dot ai.
Some great Deals https://amzn.to/49SJ3Qs
For more check out http://www.quietplease.ai
This content was created in partnership and with the help of Artificial Intelligence AI
Mark as Played
Transcript
Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
Speaker 1 (00:00):
Welcome to a Zempic weight Loss Unlocked, your source for
the latest news, research and insights on a zepic and
its impact on weight loss, health and lifestyle. If you
are following updates on a zeenpic, Recent international studies are
shedding a spotlight on why so many are both drawn
to and dropping away from this bazi medication. According to
reports from Health Day and Drugs dot Com, about half
(00:21):
of the adults who start a zempic for weight loss
end up quitting within just one year. For context, a
study out of Denmark tracked more than seventy seven thousand
new a zempic users and found that fifty two percent
gave it up before the year's end. These findings were
presented at this year's European Association for the Study of
Diabetes meeting in Vienna. So why are so many discontinuing
(00:44):
a zempic? One major reason is cost. In Denmark, the
lowest possible annual dose is over two thousand euros. In
the United States, prices can jump to more than one thousand,
four hundred dollars monthly. If uninsured people in lower income
areas were nearly fifteen percent more likely to quit early
(01:04):
for many the price tag is simply not sustainable. Long
term side effects are another factor. Drugs dot Com highlights
that those with gastrotestinal conditions, chronic illnesses, all who are
taking psychiatric medication are more likely to stop using ozenpic.
The Damish study found that people with existing GI issues
(01:25):
were nine percent more likely to quit, and those with
heart disease or other chronic conditions were ten percent more
likely to stop. Furthermore, common side effects like nausea, vomiting,
and diarrhea disproportionately drive users to discontinue. Age and gender
player role too. Younger adults were forty eight percent more
likely to stop a zempic within the first year compared
(01:47):
to older users. Men had a twelve percent greater likelihood
than women to quit. The study authors note that women
tend to see slightly better weight loss results, which might
help motivate their continued use. One important medad application is
for people living with diabetes. Originally, ozepic and similar drugs
were developed to help manage blood sugar. However, they've gained
(02:09):
popularity strictly for weight loss, and over ninety percent of
new prescriptions in some studies are written for those without diabetes.
Another recent clinical trial, reported by the journal dot Ie
looked at bumping up the standard dose to see if
results improve. By tripling the weekly dosage to seven point
two milligrams, nearly half of trial participants lost at least
(02:30):
twenty percent of their body weight. But remember higher doses
may also lead to more side effects and costs. For
younger women who are considering ozepic, caution is warranted. According
to researchers at Flinders University, there are head and reproductive
risks for women in their child bearing years. The Medical
Journal of Australia reports that most women prescribed ozebic are
(02:52):
not using effective contraception, even though these medications can pose
risks during pregnancy and fetal development. Only twenty one one
percent of women on ozepic where using contraception in one
large study of more than one point six million general
practice records. Notably, women with polycystic ovary syndrome were twice
as likely to conceive after starting ozepic, possibly because weight
(03:15):
loss can improve fertility. Lead researcher Associate Professor Luke Grescovaca
states the need for proper counseling on reproductive risks for
women starting these drugs. A final point from Science Daily
is that stopping ozepic often leads to regaining weight because
the drug works by curbing appetite and promoting the feeling
of fullness. These benefits disappear once you stop. For most
(03:39):
it is not a quick fix, but a long term commitment.
As awareness rises, so does the number of questions around cost, access,
side effect management, and the balance of risks and benefits.
Whether you are considering ozepic, currently taking it, or simply
curious about its role in the future of weight management,
keeping up with peer reviewed research and evolving guylines from
(04:00):
health agencies is crucial. Thank you for tuning in to
ozeenpic Weight Loss Unlocked. If you found this episode helpful,
please remember to subscribe so you do not mess our
next update. This has been a quiet please production. For
more check out Quiet Please dot ai
Welcome to a Zempic weight Loss Unlocked, your source for
the latest news, research and insights on a zepic and
its impact on weight loss, health and lifestyle. If you
are following updates on a zeenpic, Recent international studies are
shedding a spotlight on why so many are both drawn
to and dropping away from this bazi medication. According to
reports from Health Day and Drugs dot Com, about half
(00:21):
of the adults who start a zempic for weight loss
end up quitting within just one year. For context, a
study out of Denmark tracked more than seventy seven thousand
new a zempic users and found that fifty two percent
gave it up before the year's end. These findings were
presented at this year's European Association for the Study of
Diabetes meeting in Vienna. So why are so many discontinuing
(00:44):
a zempic? One major reason is cost. In Denmark, the
lowest possible annual dose is over two thousand euros. In
the United States, prices can jump to more than one thousand,
four hundred dollars monthly. If uninsured people in lower income
areas were nearly fifteen percent more likely to quit early
(01:04):
for many the price tag is simply not sustainable. Long
term side effects are another factor. Drugs dot Com highlights
that those with gastrotestinal conditions, chronic illnesses, all who are
taking psychiatric medication are more likely to stop using ozenpic.
The Damish study found that people with existing GI issues
(01:25):
were nine percent more likely to quit, and those with
heart disease or other chronic conditions were ten percent more
likely to stop. Furthermore, common side effects like nausea, vomiting,
and diarrhea disproportionately drive users to discontinue. Age and gender
player role too. Younger adults were forty eight percent more
likely to stop a zempic within the first year compared
(01:47):
to older users. Men had a twelve percent greater likelihood
than women to quit. The study authors note that women
tend to see slightly better weight loss results, which might
help motivate their continued use. One important medad application is
for people living with diabetes. Originally, ozepic and similar drugs
were developed to help manage blood sugar. However, they've gained
(02:09):
popularity strictly for weight loss, and over ninety percent of
new prescriptions in some studies are written for those without diabetes.
Another recent clinical trial, reported by the journal dot Ie
looked at bumping up the standard dose to see if
results improve. By tripling the weekly dosage to seven point
two milligrams, nearly half of trial participants lost at least
(02:30):
twenty percent of their body weight. But remember higher doses
may also lead to more side effects and costs. For
younger women who are considering ozepic, caution is warranted. According
to researchers at Flinders University, there are head and reproductive
risks for women in their child bearing years. The Medical
Journal of Australia reports that most women prescribed ozebic are
(02:52):
not using effective contraception, even though these medications can pose
risks during pregnancy and fetal development. Only twenty one one
percent of women on ozepic where using contraception in one
large study of more than one point six million general
practice records. Notably, women with polycystic ovary syndrome were twice
as likely to conceive after starting ozepic, possibly because weight
(03:15):
loss can improve fertility. Lead researcher Associate Professor Luke Grescovaca
states the need for proper counseling on reproductive risks for
women starting these drugs. A final point from Science Daily
is that stopping ozepic often leads to regaining weight because
the drug works by curbing appetite and promoting the feeling
of fullness. These benefits disappear once you stop. For most
(03:39):
it is not a quick fix, but a long term commitment.
As awareness rises, so does the number of questions around cost, access,
side effect management, and the balance of risks and benefits.
Whether you are considering ozepic, currently taking it, or simply
curious about its role in the future of weight management,
keeping up with peer reviewed research and evolving guylines from
(04:00):
health agencies is crucial. Thank you for tuning in to
ozeenpic Weight Loss Unlocked. If you found this episode helpful,
please remember to subscribe so you do not mess our
next update. This has been a quiet please production. For
more check out Quiet Please dot ai
Popular Podcasts
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Cardiac Cowboys
The heart was always off-limits to surgeons. Cutting into it spelled instant death for the patient. That is, until a ragtag group of doctors scattered across the Midwest and Texas decided to throw out the rule book. Working in makeshift laboratories and home garages, using medical devices made from scavenged machine parts and beer tubes, these men and women invented the field of open heart surgery. Odds are, someone you know is alive because of them. So why has history left them behind? Presented by Chris Pine, CARDIAC COWBOYS tells the gripping true story behind the birth of heart surgery, and the young, Greatest Generation doctors who made it happen. For years, they competed and feuded, racing to be the first, the best, and the most prolific. Some appeared on the cover of Time Magazine, operated on kings and advised presidents. Others ended up disgraced, penniless, and convicted of felonies. Together, they ignited a revolution in medicine, and changed the world.
The Joe Rogan Experience
The official podcast of comedian Joe Rogan.